Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Stereotactic Body Radiation Therapy Could Be Used For Non-Invasive Cardiac Ablation, Study Shows

Executive Summary

A five-patient trial shows that cardiac ablation with noninvasive stereotactic cardiac radiotherapy can reduce the burden of ventricular tachycardia. The technique could be a major improvement over catheter ablation, because its non-invasive and would allow for access to areas of the ventricular tachycardia that are inaccessible to catheter ablation. But more trials are needed to refine the technique and improve safety.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT121928

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel